NDI draft guidance

Dr Cohen: 'In my opinion, the current regulatory framework creates a facade of safety for all supplements. This creates perverse incentives to introduce poor quality and even illegal products.'

Harvard professor: ‘NDI draft guidance doesn’t go far enough’

By Elaine Watson

It might have been roundly slammed by the trade as draconian and unworkable, but according to one academic, the Food and Drug Administration’s (FDA’s) controversial draft guidance on new dietary ingredients (NDIs) does not go far enough.

UNPA: We agree with AHPA on DMAA labeling

UNPA: We agree with AHPA on DMAA labeling

By Elaine Watson

The United Natural Products Alliance (UNPA) says it agrees with the AHPA that supplement makers should not label the stimulant DMAA (1,3-Dimethylamylamine) as geranium oil or as any part of the geranium plant.

Follow us

Featured Events

View more

Products

View more

Webinars